Skip to menu Skip to content Skip to footer

2004

Conference Publication

Liposaccharides in peptide drug delivery

Blanchfield, J. T., Gallagher, O. P., Koda, Y., Alewood, P.F., Lewis, R. J. and Toth, I. (2004). Liposaccharides in peptide drug delivery. 18th American Peptide Symposium, Boston, 19-23 July, 2003. WASHINGTON: AMER CHEMICAL SOC.

Liposaccharides in peptide drug delivery

2004

Journal Article

Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct

Olive, C., Batzloff, M., Horvath, A., Clair, T., Yarwood, P., Toth, I. and Good, M. F. (2004). Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct. Indian Journal of Medical Research, 119 (Suppl.), 88-94.

Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct

2004

Conference Publication

Liposaccharide delivery system: application to conotoxin MII and endomorphin I

Blanchfield, J. T., Koda, Y., Gallagher, O. P. and Toth, I. (2004). Liposaccharide delivery system: application to conotoxin MII and endomorphin I. PSWC 2004, Kyoto, 29 May - 3 June, 2004.

Liposaccharide delivery system: application to conotoxin MII and endomorphin I

2004

Conference Publication

Liposaccharides for drug and vaccine delivery

Toth, I., Horvath, A., Karpati, L., Moyle, P., Olive, C. and Good, M. (2004). Liposaccharides for drug and vaccine delivery. 3rd International and 28th European Peptide Symposium, Prague, Czech Republic, 5–10 September 2004. Chichester, West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/psc.618

Liposaccharides for drug and vaccine delivery

2004

Journal Article

Urotensin-II-converting enzyme activity of furin and trypsin in human cells in vitro

Russell, F. D., Kearns, P., Toth, I. and Molenaar, P. (2004). Urotensin-II-converting enzyme activity of furin and trypsin in human cells in vitro. Journal of Pharmacology And Experimental Therapeutics, 310 (1), 209-214. doi: 10.1124/jpet.104.065425

Urotensin-II-converting enzyme activity of furin and trypsin in human cells in vitro

2004

Journal Article

Lipid, sugar and liposaccharide based delivery systems 2

Blanchfield, J. and Toth, I. (2004). Lipid, sugar and liposaccharide based delivery systems 2. Current Medicinal Chemistry, 11 (17), 2375-2382. doi: 10.2174/0929867043364621

Lipid, sugar and liposaccharide based delivery systems 2

2004

Journal Article

Toward the development of a synthetic group A streptococcal vaccine of high purity and broad protective coverage

Horvath, Anikó, Olive, Colleen, Karpati, Levente, Sun, H. K., Good, Hsien K. and Toth, Istvan (2004). Toward the development of a synthetic group A streptococcal vaccine of high purity and broad protective coverage. Journal of Medicinal Chemistry, 47 (16), 4100-4104. doi: 10.1021/jm040041w

Toward the development of a synthetic group A streptococcal vaccine of high purity and broad protective coverage

2004

Conference Publication

Liposaccharide delivery system: Application to Conotoxin MII and Endomorphin 1

Blanchfield, J. T., Koda, Y., Gallagher, O. P. and Toth, I. (2004). Liposaccharide delivery system: Application to Conotoxin MII and Endomorphin 1. 20th RACI Organic Chemistry Conference, Cairns, 4-8 July, 2004.

Liposaccharide delivery system: Application to Conotoxin MII and Endomorphin 1

2004

Journal Article

Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer model

Matthias, A., Blanchfield, J. T., Penman, K. G., Toth, I., Lang, C. S., De Voss, J. J. and Lehmann, R. P. (2004). Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer model. Journal of Clinical Pharmacy And Therapeutics, 29 (1), 7-13. doi: 10.1046/j.1365-2710.2003.00530.x

Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer model

2004

Conference Publication

Novel vaccine delivery systems

Toth, I. (2004). Novel vaccine delivery systems. GPEN 2004, Kyoto, 26-28 May, 2004.

Novel vaccine delivery systems

2004

Journal Article

Nucleophilic substitution reactions of pyranose polytosylates

McGeary, R. P., Rasoul Amini, S., Tang, V. W. S. and Toth, I. (2004). Nucleophilic substitution reactions of pyranose polytosylates. Journal of Organic Chemistry, 69 (8), 2727-2730. doi: 10.1021/jo035779k

Nucleophilic substitution reactions of pyranose polytosylates

2004

Journal Article

Design, Synthesis, and Evaluation of a Liposaccharide Drug Delivery Agent: Application to the Gastrointestinal Absorption of Gentamicin

Ross, B. P., DeCruz, S. E., Lynch, T. B., Davis-Goff, K. and Toth, I. (2004). Design, Synthesis, and Evaluation of a Liposaccharide Drug Delivery Agent: Application to the Gastrointestinal Absorption of Gentamicin. Journal of Medicinal Chemistry, 47 (5), 1251-1258. doi: 10.1021/jm030474j

Design, Synthesis, and Evaluation of a Liposaccharide Drug Delivery Agent: Application to the Gastrointestinal Absorption of Gentamicin

2004

Conference Publication

Lipid and carbohydrate based macromolecules in drug and vaccine delivery

Toth, I., Horvath, A., Blanchfield, J. T., Olive, C., Good, M. F., Wimmer, N. and Rakoczy, E.P. (2004). Lipid and carbohydrate based macromolecules in drug and vaccine delivery. 18th American Peptide Symposium, Boston, 19-23 July, 2004.

Lipid and carbohydrate based macromolecules in drug and vaccine delivery

2004

Journal Article

Lipid core peptide technology and group A streptococcal vaccine delivery

Olive, C., Batzloff, M.R. and Toth, I. (2004). Lipid core peptide technology and group A streptococcal vaccine delivery. Expert Review of Vaccines, 3 (1), 43-58. doi: 10.1586/14760584.3.1.43

Lipid core peptide technology and group A streptococcal vaccine delivery

2004

Conference Publication

A novel liposaccharide system for the delivery of Endormorphin 1

Koda, Y., Blanchfield, J. T., Okada, Y. and Toth, I. (2004). A novel liposaccharide system for the delivery of Endormorphin 1. PSWC 2004, Kyoto, 29 May- 3 June, 2004.

A novel liposaccharide system for the delivery of Endormorphin 1

2004

Conference Publication

Incorporation of lipoamino acids - peptide conjugates within liposomes: Effect of alkyl chain length, number of alkyl chains and method of liposome preparation

Liang, M.T., Davies, N. M. and Toth, I. (2004). Incorporation of lipoamino acids - peptide conjugates within liposomes: Effect of alkyl chain length, number of alkyl chains and method of liposome preparation. Annual Conference of the APSA, 2004, Melbourne, Vic, Australia, 4-7 December, 2004. Mount Waverley, Victoria: Australasian Pharmaceutical Science Association.

Incorporation of lipoamino acids - peptide conjugates within liposomes: Effect of alkyl chain length, number of alkyl chains and method of liposome preparation

2004

Journal Article

Mucosal immunization: Adjuvants and delivery systems

Moyle, P.M., McGeary, R. P., Blanchfield, J. T. and Toth, I. (2004). Mucosal immunization: Adjuvants and delivery systems. Current Drug Delivery, 1 (4), 385-396. doi: 10.2174/1567201043334588

Mucosal immunization: Adjuvants and delivery systems

2004

Conference Publication

Preparation of peptide functionalized nanoparticles by interfacial polymerisation of w/o microemulsions

Liang, M. T., Davies, N. M. and Toth, I. (2004). Preparation of peptide functionalized nanoparticles by interfacial polymerisation of w/o microemulsions. CTP 2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing Asia.

Preparation of peptide functionalized nanoparticles by interfacial polymerisation of w/o microemulsions

2003

Edited Outputs

Mini-Reviews in Medicinal Chemistry

Mini-Reviews in Medicinal Chemistry. (2003). 3 (7)

Mini-Reviews in Medicinal Chemistry

2003

Journal Article

Development of lipid-core-peptide (LCP) based vaccines for the prevention of the group A streptococcal (GAS) infection

Moyle, P. M., Horvath, A., Olive, C., Good, M. F. and Toth, I. (2003). Development of lipid-core-peptide (LCP) based vaccines for the prevention of the group A streptococcal (GAS) infection. Letters In Peptide Science, 10 (5-6), 605-613. doi: 10.1007/BF02442594

Development of lipid-core-peptide (LCP) based vaccines for the prevention of the group A streptococcal (GAS) infection